Projects per year
Abstract
Controlling the succession of chemical processes with high specificity in complex systems is advantageous for widespread applications, from biomedical research to drug manufacturing. Despite synthetic advances in bioorthogonal and photochemical methodologies, there is a need for generic chemical approaches that can universally modulate photodynamic reactivity in organic photosensitizers. Herein we present a strategy to fine-tune the production of singlet oxygen in multiple photosensitive scaffolds under the activation of bioresponsive and bioorthogonal stimuli. We demonstrate that the photocatalytic activity of nitrobenzoselenadiazoles can be fully blocked by site-selective incorporation of electron-withdrawing carbamate moieties and restored on demand upon uncaging with a wide range of molecular triggers, including abiotic transition-metal catalysts. We also prove that this strategy can be expanded to most photosensitizers, including diverse structures and spectral properties. Finally, we show that such advanced control of singlet oxygen generation can be broadly applied to the photodynamic ablation of human cells as well as to regulate the release of singlet oxygen in the semi-synthesis of natural product drugs.
Original language | English |
---|---|
Article number | 7689 |
Journal | Nature Communications |
Volume | 15 |
Issue number | 1 |
DOIs | |
Publication status | Published - 3 Sept 2024 |
Fingerprint
Dive into the research topics of 'Tuning singlet oxygen generation with caged organic photosensitizers'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Metabolic photosensitizers for photodynamic therapy of brain cancer
Vendrell Escobar, M. (Principal Investigator) & Unciti-Broceta, A. (Co-investigator)
1/03/22 → 28/02/25
Project: Research
Equipment
-
Edinburgh Drug Discovery
Unciti-Broceta, A. (Manager), Webster, S. (Manager) & Carragher, N. (Manager)
Deanery of Molecular, Genetic and Population Health SciencesFacility/equipment: Facility